Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
$534M |
| 2 |
Amazon
AMZN
|
$432M |
| 3 |
Abbott
ABT
|
$420M |
| 4 |
Adobe
ADBE
|
$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
$472M |
| 2 |
Bank of America
BAC
|
$426M |
| 3 |
TE Connectivity
TEL
|
$399M |
| 4 |
Atlassian
TEAM
|
$364M |
| 5 |
Goldman Sachs
GS
|
$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Industrials | 9.76% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Novartis
NVS
$249B
| $258M | 0.15% |
2,552,713
+19,776
| +0.8% | +$2M |
|
152
Analog Devices
ADI
$121B
| $255M | 0.15% |
1,283,941
+300,918
| +31% | +$59.8M |
|
153
Biohaven
BHVN
$1.7B
| $253M | 0.15% |
5,901,343
+575,762
| +11% | +$24.6M |
|
154
Core & Main
CNM
$12.5B
| $247M | 0.15% |
6,119,129
+969,599
| +19% | +$39.2M |
|
155
Lantheus
LNTH
$3.66B
| $245M | 0.15% |
3,947,571
+857,421
| +28% | +$53.2M |
|
156
Sempra
SRE
$53.6B
| $245M | 0.15% |
3,272,675
+317,891
| +11% | +$23.8M |
|
157
Keysight
KEYS
$28.7B
| $242M | 0.14% |
1,522,857
+802,233
| +111% | +$128M |
|
158
Blackbaud
BLKB
$3.22B
| $242M | 0.14% |
2,787,519
+27,136
| +1% | +$2.35M |
|
159
Schlumberger
SLB
$53.7B
| $240M | 0.14% |
4,609,251
+1,400,928
| +44% | +$72.9M |
|
160
Rivian
RIVN
$16.6B
| $239M | 0.14% |
10,176,795
+412,045
| +4% | +$9.67M |
|
161
Icon
ICLR
$13.7B
| $239M | 0.14% |
843,356
+42,419
| +5% | +$12M |
|
162
Intuitive Surgical
ISRG
$163B
| $237M | 0.14% |
703,962
+299,348
| +74% | +$101M |
|
163
Veralto
VLTO
$26.5B
| $237M | 0.14% |
+2,881,576
| New | +$237M |
|
164
Waters Corp
WAT
$17.8B
| $233M | 0.14% |
709,074
+5,216
| +0.7% | +$1.72M |
|
165
PNC Financial Services
PNC
$81.7B
| $229M | 0.14% |
1,475,961
+16,018
| +1% | +$2.48M |
|
166
Fidelity National Information Services
FIS
$35.9B
| $228M | 0.14% |
3,795,077
+44,260
| +1% | +$2.66M |
|
167
Walker & Dunlop
WD
$2.84B
| $226M | 0.13% |
2,032,290
+12,655
| +0.6% | +$1.41M |
|
168
Vistra
VST
$64.3B
| $221M | 0.13% |
5,726,945
+1,692,266
| +42% | +$65.2M |
|
169
Burlington
BURL
$19B
| $219M | 0.13% |
1,125,325
+13,511
| +1% | +$2.63M |
|
170
Gildan
GIL
$8.21B
| $219M | 0.13% |
6,615,804
-596,450
| -8% | -$19.7M |
|
171
Ziff Davis
ZD
$1.53B
| $217M | 0.13% |
3,229,351
-512,336
| -14% | -$34.4M |
|
172
Cimpress
CMPR
$1.49B
| $216M | 0.13% |
2,702,449
+16,332
| +0.6% | +$1.31M |
|
173
Cytokinetics
CYTK
$5.95B
| $214M | 0.13% |
2,568,405
+75,079
| +3% | +$6.27M |
|
174
RB Global
RBA
$21.5B
| $213M | 0.13% |
3,181,335
+16,198
| +0.5% | +$1.08M |
|
175
Tesla
TSLA
$1.09T
| $213M | 0.13% |
856,263
-52,339
| -6% | -$13M |
|